Price-demand elasticity research

Providing evidence-based value pricing strategies to the pharmaceutical industry

Optimize performance against competition both within and outside your TC

Inpharmation’s Pharma-Specific™ price-demand elasticity research has been developed by experts to overcome the challenges faced when running traditional pharmaceutical pricing research:
  • Price-elasticity demand research goes far beyond traditional pricing research, to give you powerful strategic recommendations based on a number of different pricing landscape scenarios.
  • Running pharmaceutical price-elasticity demand research when you have a limited number of respondents, in this case limited payers, requires efficient survey techniques.
  • Inpharmation’s validated pharmaceutical price-elasticity demand research methods are subject to up to 79% less error than traditional pricing research methods*.
*Independent comparison of two direct pricing methodologies
%
Reduction in error compared to traditional pricing methodologies.*

Traditional payer research is often inflexible and cannot adjust to a large number of different market conditions, for example different numbers of competitors, different competitor pricing strategies and different possibilities for competitor price evolutions.

Inpharmation’s Pharma-Specific™ price-demand elasticity research has been designed to provide strategic pricing insights, to understand how competitor pricing strategies affect your brand:
  • Pharmaceutical lifecycle pricing: Inpharmation’s Pharma-Specific price-demand elasticity research is specific for all stages of your pharmaceutical brand lifecycle pricing, whether you’re developing a pricing strategy pre-launch, need to run in-market price optimization due to competitor price tactics or need to optimize prices in the light of further indication launches.
  • Going beyond the brand: Inpharmation’s Pharma-Specific price-demand elasticity research can investigate supra-brand pharma pricing effects, investigating whether brand (and biosimilar) pricing strategy can impact usage of the therapeutic class or treatment mechanism.
  • Scenario analysis: Inpharmation’s decades of systems modelling experience means project-specific options can include scenario analysis engines and system-modelling simulators.
%
Of the top-20 global pharma companies use Inpharmation’s pricing solutions.

"Europe's most respected pharma forecasting & pricing specialist consultancy."

Centre for Executive Leadership

Evidence-based approach to price-demand elasticity research

Inpharmation’s Pharma-Specific price-demand elasticity research is the premier solution to pharmaceutical pricing and market questions when your business question needs a fine-tuned quantitative answer. This is because Inpharmation’s research techniques are structured in a precise way, and can be compared rigorously against other structured techniques. In this way, the best techniques can be selected and deployed to help recommend a value-based pricing strategy.

Unstructured interviews cannot be scientifically tested as no two unstructured interviews are ever the same. (Although, we do know from a vast body of empirical research that unstructured judgments produce much worse predictions than structured techniques.)

Inpharmation deploys a range of evidence-based quantitative pharmaceutical pricing and market access research techniques and these can be used throughout the development of a pharmaceutical product. In fact, 70% of the top-20 global pharma companies already use Inpharmation’s pricing solutions.

Download the full Case Study by filling in the form:
Scroll Top